Trials / Completed
CompletedNCT02529488
Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00
Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting IOL Model TFNT00
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 167 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate visual outcomes and assess safety at 12 months (330-420 days) post bilateral implantation of the AcrySof® IQ PanOptix™ Presbyopia-Correcting IOL.
Detailed description
This study will be conducted in regions where the test article is approved at the time of study start.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | AcrySof® IQ PanOptix™ Presbyopia-Correcting IOL | Multifocal IOL(near, intermediate, distance) implanted for long-term use over the lifetime of the cataract patient |
Timeline
- Start date
- 2015-09-07
- Primary completion
- 2016-11-30
- Completion
- 2017-06-26
- First posted
- 2015-08-20
- Last updated
- 2018-07-02
- Results posted
- 2018-04-06
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02529488. Inclusion in this directory is not an endorsement.